 

AGS Transact Technologies Limited
Annexure VI: Notes to the Revised Restated Consolidated Financial Information

Note 36
Employee Stock Option Plan (ESOP)

For the five month pet

 

od ended 34 August 2021

(0n 29 February 2012, the Board of Directors approved the Equity-Setled Employee Stock Option Scheme (ESOS 2012) for issue of stock options tothe key employees of the Company and others as approved by

the Board of Directors comprising of 2,319,588 options convertible into one equity share each

‘The key terms and conditions related tothe grants under these plans areas follows; all options are tobe settled by the delivery of shares.

 

 

[Particulars [ESOS 2012
frranche 1: 05 Mareh 2012
Hrranche 2: 24 July 2012

essen HTranche 3: 01 February 2015

[Tranche 4: 01 February 2015
HTranche 5: 16 August 2018
[Tranche 6: 12 August 2021

 

[Fair Value at Grant Date IRs. 39.13 to Rs. 176.10

 

lFair Value of Options at Grant Date

 

IRs. 7.77 to Rs. 121.26

 

 

 

 

 

 

[Exercise Price IRs. Sooo Re, 110.1
Vesting period [10-3 years from the respective date of grant

Exercise period 5 years or 1 year from the date of listing whichever is later (o be reckoned from date of first vesting)
[Expected Life 2S toa years

 

* There as been an amendment tothe exercise year of the ESOP schemes

 

“The details of activity under ESOS 2012 are summarised below:-

Tachuding bons Iesue

 

particulars

‘Bi August 2021] 31 March 2027

 

Bi March 2020

31 March 2019)

 

(No. of options) | (No. of options) | (No. of options) | (No. of options)
ESOS 2012| ESOS 2013| ESOS 2012] ESOS 2012
Jourstanding atthe beginning of the year / period 1,960,000 1,960,000 1,975,000 1,168,000
|Granted during the year / period 129,740 : - 281,000
exercised during the year / period : - . 74,000
Lapsed during the year ’ period 89,000 : 15,000
[Outstanding atthe end ofthe year / period 2,000,740 1,960,000 1,960,000 1,975,000
lexercisable at the end ofthe year / period 1,871,000 1,665,560 1,379,780 1,094,000
Weighted average remaining contractual life (years) 0103.50] 0251 01351 010451

Weighted average fair value of options granted (Rs.)
Weighted average exercise price (Rs.)

7.77 19 140.66|
39,13 0 111.13

2.77 0 121.26
39.13 0 111.13

7.77 121.26
39.13 111.13]

2.77 «121.26
39.13 0 111.13]

 

‘Note: The above options are after considering a bonus Issue of 31 during the year ended 31 March 2015,

“The Black and Scholes Options Pricing model had been used for computing the we

  

ed average fae value considering the following inputs on the date of gran

 

 

 

 

 

 

[Particulars ‘Tranche 1] Tranche 2 Tranche 3| ‘Tranche 4] ‘Tranche 5| ‘Tranche 6|
[Dividend Yield 0.00%] 0.00%] 0.00%] 0.00%] 0.00%] 057%
lexpected Volatility 0.00%| o.00%| 0.00%| 0.00%| 232,39 11.20%6|
Risk fre imterest rate 8.30%| 7.93% 9.05%| 9.05%| 7.97%| 5.74%6|
| Weighted average share price (Rs.) 38.13] 50.09 152.46| 152.46| 93.00 176.10]
exercise Price (Rs.) 38.13] 313] 38.13] nig] 38.13] 39.13]
expected life of options granted in oars 3.04] 2.1] 250] 231 451 35

 

 

 

 

 

Of the ESOS 2012 above,

 

928 options are reserved for issue of equity shares ofthe Company,

(On 3 February 2015, the Board of Directors approved the Equity-Setled Employee Stock Option Scheme (ESOS 2015) for issue of stock options tothe key employees of the Company and others as approved by

the Board of Directors comprising of 1,216,000 options convertible into one equity share each
(On 4th August 2021, the Board of Directors increased the existing ESOP Pool by 2,200,000 options.

“The key terms and conditions related tothe grants under these plans areas follows; all options are tobe settled by the delivery of shares,

 

[Particulars [ESOS 2015

 

[Grant Date [Tranche 1: 16 August 2018

 

Tranche 2: 12 August 2021

 

[Fair Value at Grant Date IRs. 93.00 to Rs 176.10

 

[Exercise Price IRs. 39.135

 

Vesting period

 

10-3 years from the respective date of grant

 

 

[Exercise peri 5 years or 1 year from the date of listing whichever Is later (0 be reckoned [rom date of first vesting)

 

 

[Expected Life

5105.5 years

 

 

‘The details of activity under ESOS 2015 are summarised below:

 

 

ae ‘BH August 2021 31 March2021 31 March 2020 31 March 2019
(No.of options) (No. of options) (No. of options) (No.of options)
ESOS 2015, ESOS 2015, ESOS 2015 ESOS 2015
(Outstanding atthe beginning of the year / period 1,024,500 1,110,500 1,184,500
Granted during the year / period 2,402,920 : : 1,216,000
Exercised during the year / period 7 : : -
Lapsed during the year / period 14,000 86,000 74,000 31,500
(Outstanding atthe end ofthe year / period 3,413,420 1,024,500 4,110,500 1,184,500
Exercisable at the end ofthe year / period 1,010,500 676,170 366,465
Weighted average remaining contractual life (years) 1.51 103.50 251 351 451
Weighted average fair value of options granted (Rs.) 92.00 to 176.10 66.12 66.12 66.12
Weighted average exercise price (Rs.) 3913, 39.13 39.13, 39.13,

280

 
